To compare nitroglycerin and terbutaline for intrapartum fetal heart rate...
Date First Received: September 12, 2005
Last Updated: May 7, 2008
Verified by: Stanford University, May 2008
Clinical Trial Phase: N/A | Start Date:
Overall Status: Active, not recruiting
Estimated Enrollment: 0
Brief Summary
Official Title: “Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation”
Condition Keyword(s):
Intervention(s):
To compare nitroglycerin and terbutaline for intrapartum fetal heart rate resuscitation
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Active Control, Single Group Assignment
Intervention(s) in this Clinical Trial
- Drug: nitroglycerin and terbutaline
Outcome Measures for this Clinical Trial
Primary Measures
- resolution of abnormal fetal heart tracing
Secondary Measures
- cesarean section rate
- operative vaginal delivery rate
- neonatal outcomes
Criteria for Participation in this Clinical Trial
Inclusion Criteria::
- nonreassuring fetal heart rate tracing Exclusion Criteria:- maternal cardiac disease, placental abruption, intrauterine growth restriction, prior cesarean section
Gender Eligibility for this Clinical Trial: Female
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Sponsor Information
Lead Sponsor: Stanford University
Overall Clinical Trial Officials and Contacts
Yasser Yehia El-Sayed Principal Investigator Stanford University
Additional Information
Information obtained from ClinicalTrials.gov on October 10, 2008
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00185887
Study ID Number: 79504
ClinicalTrials.gov Identifier: NCT00185887
Health Authority: United States: Institutional Review Board
Clinical Trials Authorship and Review
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
